Position in GILD
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$45,013,678
-$15,683,071 QoQ
Shares Held
356,290
-18.2% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
1.86%
of 13F equity value
Holder Rank
#222
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RNC CAPITAL MANAGEMENT LLC holds $281,592,319 across 11 Drug Manufacturers - General names. GILD ranks #4 (16.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
517,240 | $66,465,340 | |
| 2 | ABBV |
AbbVie Inc.
|
236,727 | $59,569,982 | |
| 3 | JNJ |
Johnson & Johnson
|
191,013 | $48,511,571 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
356,290 | $45,013,678 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
645,383 | $37,186,968 | |
| 6 | LLY |
ELI LILLY & Co
|
13,549 | $16,251,078 | |
| 7 | AZN |
Astrazeneca PLC
|
32,535 | $6,169,286 | |
| 8 | AMGN |
Amgen Inc
|
2,755 | $997,640 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,013,678 | 356,290 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $60,696,749 | 435,508 | Shares | Sole | 2026-08-06 | |
| 2025-12-31 | $55,477,375 | 451,991 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $49,399,884 | 445,044 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $50,544,413 | 455,889 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $51,160,349 | 456,585 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $42,367,347 | 458,670 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $54,447,205 | 649,418 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $44,556,568 | 649,418 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $45,907,313 | 626,721 | Shares | Sole | 2024-08-07 | |
| 2023-12-31 | $54,960,019 | 678,435 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $51,096,040 | 681,826 | Shares | Sole | 2023-12-27 | |
| 2023-06-30 | $54,603,632 | 708,494 | Shares | Defined | 2023-07-21 | |
| 2023-03-31 | $58,658,047 | 706,979 | Shares | Defined | 2023-04-21 | |
| 2022-12-31 | $60,519,184 | 704,941 | Shares | Defined | 2023-01-11 | |
| 2022-09-30 | $42,325,509 | 686,100 | Shares | Defined | 2022-10-18 | |
| 2022-06-30 | $33,392,358 | 540,242 | Shares | Defined | 2022-07-22 | |
| 2022-03-31 | $31,351,789 | 527,364 | Shares | Defined | 2022-07-22 | |
| 2021-12-31 | $38,455,635 | 529,619 | Shares | Defined | 2022-02-04 | |
| 2021-09-30 | $31,135,567 | 445,749 | Shares | Defined | 2021-11-02 | |
| 2021-06-30 | $30,488,797 | 442,765 | Shares | Defined | 2021-07-20 | |
| 2021-03-31 | $18,504,603 | 286,316 | Shares | Defined | 2021-04-26 | |
| 2020-12-31 | $12,328,165 | 211,606 | Shares | Defined | 2021-01-13 | |
| 2020-09-30 | $19,919,004 | 315,224 | Shares | Defined | 2020-12-03 | |
| 2020-06-30 | $25,362,732 | 329,643 | Shares | Defined | 2020-07-23 | |
| 2020-03-31 | $24,030,181 | 321,431 | Shares | Defined | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||